[Clinico-epidemiologic significance of episomal resistance to antibiotics in shigellae].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000382:microbiology; D015643:Erythromycin Ethylsuccinate / Q000494:pharmacology / Q000627:therapeutic use; D005111:Extrachromosomal Inheritance; D005243:Feces / Q000382:microbiology; D005260:Female; D005664:Furazolidone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008433:Mathematics; D008875:Middle Aged; D012763:Shigella flexneri / Q000187:drug effects*; D012764:Shigella sonnei / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013424:Sulfanilamides / Q000627:therapeutic use; D013752:Tetracycline / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors
D000900:Anti-Bacterial Agents; D013424:Sulfanilamides; D015643:Erythromycin Ethylsuccinate; D005664:Furazolidone; D002701:Chloramphenicol; D013752:Tetracycline; D013307:Streptomycin
Kliniko-épidemiologicheskoe znachenie épisomnoĭ ustoĭchivosti shigell k antibiotikam